Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-060466
Filing Date
2025-06-18
Accepted
2025-06-18 07:03:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2516079d3_defa14a.htm DEFA14A 12944
2 GRAPHIC tm2516079d3_defa14aimg01.jpg GRAPHIC 190788
3 GRAPHIC tm2516079d3_defa14aimg02.jpg GRAPHIC 148817
  Complete submission text file 0001104659-25-060466.txt   475090
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 251055115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)